GlassScriptPhysician profile
Cielo Navato-Dehning
NPI 1093784910
$1,371.72
in general payments reported to CMS, 2019-2025
9 companies · $20.72 in 2025
The $20.72 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $374 · 2020: $302 · 2021: $297 · 2022: $57.34 · 2023: $142 · 2024: $179 · 2025: $20.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $341.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $528.43 | 2019-2020 | |
| Piramal Critical Care | $397.49 | 2020-2024 | |
| Medtronic, INC. | $233.10 | 2021-2025 | Synchromedii |
| Saol Therapeutics INC. | $118.73 | 2019-2021 | |
| Grt US Holding, INC. | $31.41 | 2020-2021 | |
| Amneal Pharmaceuticals LLC | $20.09 | 2022 | |
| Pfizer INC. | $15.53 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.80 | 2019 | |
| Boston Scientific Corporation | $13.14 | 2023 | Watchman Access System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cielo Navato-Dehning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.